Immix Biopharma Inc (IMMX)
Healthcare
Biotechnology
8.30 $
-2.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Immix Biopharma Inc (IMMX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -24 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.8 | -0.4 | -1.6 | -7.4 | -11 | -15 | -24 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.4 | |
| – | 0.0 | 0.2 | 0.6 | 2.6 | 3.0 | 2.4 | |
| 0.6 | 0.6 | 23 | 0.6 | – | – | – | |
| 0.2 | 0.2 | -0.4 | 0.2 | 1.7 | 4.0 | 2.7 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 1.2 | 0.7 | |
| 0.0 | 0.0 | 0.0 | – | -0.1 | -1.2 | -7.2 | |
| – | – | 0.0 | -0.1 | 0.0 | – | – | |
| 1.1 | 0.2 | 0.2 | -0.1 | 0.0 | – | – | |
| 1.1 | 19 | 19 | 3.2 | 15 | 16 | 107 | |
| 0.3 | -0.3 | 17 | -4.2 | 4.1 | 0.2 | 76 | |
| -0.8 | -0.4 | -1.6 | -7.4 | -11 | -16 | -25 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.